Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis

Gut Microbes. 2022 Jan-Dec;14(1):2149020. doi: 10.1080/19490976.2022.2149020.

Abstract

Rheumatoid arthritis (RA) is closely associated with the oral and gut microbiomes. Fungal cell wall components initiate inflammatory arthritis in mouse models. However, little is known regarding the role of the fungal community in the pathogenesis of RA. To evaluate the association between RA and the gut microbiome, investigations of bacterial and fungal communities in patients with RA are necessary. Therefore, we investigated the compositions and associations of fecal bacterial and fungal communities in 30 healthy controls and 99 patients with RA. The relative abundances of Bifidobacterium and Blautia decreased, whereas the relative abundance of Streptococcus increased, in patients with RA. The relative abundance of Candida in the fecal fungal community was higher in patients with RA than in healthy controls, while the relative abundance of Aspergillus was higher in healthy controls than in patients with RA. Candida species-specific gene amplification showed that C. albicans was the most abundant species of Candida. Ordination analysis and random forest classification models supported the findings of structural changes in bacterial and fungal communities. Aspergillus was the core fecal fungal genus in healthy controls, although Saccharomyces spp. are typically predominant in Western cohorts. In addition, bacterial-fungal association analyses showed that the hub node had shifted from fungi to bacteria in patients with RA. The finding of fungal dysbiosis in patients with RA suggests that fungi play critical roles in the fecal microbial communities and pathogenesis of RA.

Keywords: Aspergillus; Candida; Fecal microbiota; dysbiosis; rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Rheumatoid*
  • Gastrointestinal Microbiome*
  • Mice

Grants and funding

This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) grant funded by Korean Government (MSIT) (NRF-2016M3A9D391585722 to C.-H.P. and NRF-2021M3H9A1096935 to Y.-H.L.) and an intramural grant from the Korea Institute of Science and Technology.